numares GROUP Corporation
Numares is enhancing research and clinical outcomes with improved precision medicine. Numares’ AXINON® System, a high-throughput nuclear magnetic resonance (NMR) spectroscopy platform, generates highly accurate metabolic biomarker data for assessment of renal function, hepatorenal syndromes and cardiorenal disease. With Magnetic Group Signaling (MGS®) technology, machine learning standardizes NMR results across a spectrum of metabolic constellations for multiple research applications. Booth 2533, numares.com.
Additional Info
First-time Exhibitor:
No